26 donorss.
| Date | Contributor | Type | Employer | Occupation | Amount |
|---|---|---|---|---|---|
| 2025-01-31 | Richard C Ascroft | IND | Takeda Pharmaceuticals U.S.A. Inc. | SVP Head of US Plasma Derived Therapie | $576.90 |
| 2025-01-31 | Dana Mendenhall | IND | Takeda Pharmaceuticals U.S.A. Inc. | Global Head of PDT Commercial and Port | $576.90 |
| 2025-01-31 | Pallavi Garg | IND | Takeda Pharmaceuticals U.S.A. Inc. | Head of US Oncology | $576.90 |
| 2025-01-31 | Meena Subramanyam | IND | Takeda Development Center Americas Inc | VP Global Program Leader | $576.90 |
| 2025-01-31 | Jennifer Norton | IND | Takeda Pharmaceuticals America Inc. | Senior Vice President U.S. Patient and | $576.90 |
| 2025-01-31 | Kirsten T Powell | IND | Takeda Pharmaceuticals America Inc. | VP Federal Gov Affairs Public Policy & | $576.90 |
| 2025-01-31 | Andrew G Kaplan | IND | Takeda Pharmaceuticals America Inc. | SVP US Public Affairs | $576.90 |
| 2025-01-31 | Ramona A Sequeira | IND | Takeda Pharmaceuticals U.S.A. Inc. | President Global Portfolio Division | $576.90 |
| 2025-01-31 | Julie Kim | IND | Takeda Pharmaceuticals U.S.A. Inc. | President US Business Unit | $576.60 |
| 2025-01-31 | Andrew Plump | IND | Takeda Development Center Americas Inc | President Research and Development | $576.00 |
| 2025-01-31 | Onelia A Vera | IND | Takeda Pharmaceuticals America Inc. | Head Counsel Hematology & Rare Disease | $450.00 |
| 2025-01-31 | Elizabeth Lewis | IND | Takeda Pharmaceuticals America Inc. | Head of Global Oncology Patient Value | $450.00 |
| 2025-01-31 | Laura E Cline | IND | Takeda Pharmaceuticals America Inc. | VP Therapeutic Area Policy and Patient | $375.00 |
| 2025-01-31 | Brandon J Monk | IND | Takeda Pharmaceuticals U.S.A. Inc. | SVP Head of Gastroenterology Business | $300.00 |
| 2025-01-31 | Rebecca Mandell | IND | Takeda Pharmaceuticals America Inc. | Director Federal Government Affairs | $300.00 |
| 2025-01-31 | Katherine C Smith | IND | Takeda Pharmaceuticals America Inc. | Dir Public Affairs and Operations | $300.00 |
| 2025-01-31 | Serina M Fischer | IND | Takeda Pharmaceuticals U.S.A. Inc. | Product Strategy Lead Orexin | $297.96 |
| 2025-01-31 | Rodney R Dickson | IND | Takeda Pharmaceuticals America Inc. | Sr. Director Therapeutic Policy and Ad | $288.45 |
| 2025-01-31 | John T Schlatter | IND | Takeda Pharmaceuticals America Inc. | Sr Dir State Government & External Aff | $270.36 |
| 2025-01-31 | Kathryn S Mathias | IND | Takeda Pharmaceuticals America Inc. | Associate Director Launch Excellence | $270.00 |
| 2025-01-31 | Shelley S Stewart | IND | Takeda Pharmaceuticals America Inc. | Director Federal Government Affairs | $264.51 |
| 2025-01-31 | William Baggett | IND | Takeda Pharmaceuticals America Inc. | Assoc Dir State Government & External | $240.00 |
| 2025-01-31 | Shawn Sullivan | IND | Takeda Pharmaceuticals America Inc. | Associate Director Public Affairs and | $240.00 |
| 2025-01-31 | Scott A Godsoe | IND | Takeda Pharmaceuticals U.S.A. Inc. | US Region Controller | $225.00 |
| 2025-01-31 | Michael Thien | IND | Takeda Development Center Americas Inc | Head of Pharmaceutical Sciences | $225.00 |
| 2025-01-31 | Christopher W Arendt | IND | Takeda Development Center Americas Inc | Chief Scientific Officer | $225.00 |